Invio Automation Acquires Calvary Robotics to Expand Automation Capabilities in High-Growth End Markets

NEW YORK & LANSING, Mich.–(BUSINESS WIRE)–Invio Automation (“Invio”), a leading provider of advanced automation solutions and a portfolio company of Arsenal Capital Partners, announced today that it has acquired Calvary Robotics Inc. (“Calvary”). The terms of the transaction were not disclosed.

Logo INVIO Azur
Logo INVIO Azur

Headquartered in Webster, NY with additional locations in South Carolina and Malaysia, Calvary is a leader in robotics, advanced automation solutions, and material handling systems. With more than 30 years of experience, Calvary delivers systems design and simulation services, automation equipment manufacturing, and lifecycle support to a global customer base. Calvary serves a range of high-growth end markets and applications, including medical device and life sciences, advanced manufacturing, and transportation.

This acquisition expands Invio’s manufacturing footprint while adding complementary engineering and application expertise. Together, the combined business can better serve the complex automation and high-precision system needs of customers from concept and simulation through build, deployment, and continuous optimization. Invio designs and delivers automation systems purpose-built around manufacturers’ production flow, combining motion, custom positioning, throughput-focused design, and disciplined execution.

“We are thrilled to welcome Calvary Robotics to the Invio team,” said Achilli Sfizzo, CEO of Invio Automation. “This acquisition is an important growth accelerator for Invio as it expands our capabilities, talent, and global reach. Calvary reflects our continued commitment to invest significant capital to build the preferred automation partner for high-value material movement and precision assembly, where system performance, reliability, and execution matter most.”

Robert Lague, CEO of Calvary Robotics, added, “Joining Invio marks an exciting next chapter for Calvary. Together, we bring deep engineering expertise that will enable customers to achieve higher productivity, efficiency and manufacturing flexibility. The two organizations share a performance-driven culture based on operational excellence and customer centricity.”

Houlihan Lokey served as exclusive financial advisor to Calvary Robotics on the transaction.

About Invio Automation

Invio Automation is a leading provider of advanced automation systems for complex material handling and high-precision manufacturing. The company partners with customers in high-growth end markets including medical device and life sciences, semiconductor, renewable energy, mobility and transportation, and advanced manufacturing.

Invio designs, builds, and deploys automation solutions spanning autonomous material movement, custom automation and robotics integration, and precision tooling. With full-lifecycle capabilities from system design and simulation through deployment and ongoing optimization, including ‘Factory of the Future’ consulting, Invio helps manufacturers scale operations while maintaining quality and flexibility. For more information, please visit www.invioautomation.com.

About Arsenal Capital Partners

Arsenal Capital Partners is a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds totaling over $10 billion, completed more than 300 platform and add-on acquisitions, and achieved more than 35 realizations. Driven by a commitment to unlock potential in people, businesses, and technologies, the firm partners with management teams to build strategically important companies with leading market positions, high growth, and high value-add. For more information, visit www.arsenalcapital.com.

Contacts

Contact for Invio Automation:
Erina Lambeth

[email protected]

Contact for Arsenal:
Ellen Pavlovsky

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.